|Day Low/High||112.45 / 114.04|
|52 Wk Low/High||101.36 / 132.13|
Do we have to run for the hills? Not necessarily.
Newmont Mining will acquire Goldcorp in a $10 billion deal, and here's how I'd trade Newmont.
My stated reason for being in Pfizer all along has been price stability and income.
This is the kind of reversal that happens in a bull market.
Could there be more M&A this year than Wall Street had thought? Also, GE's quest for more liquidity took another baby step Monday.
Jim Cramer says companies that innovate become market-leading stocks, and can create tremendous wealth.
Tesla, the big pharma mergers and General Electric are some of the top stories on TheStreet.
Luxoft is to be bought for about $2 billion by DXC Technology.
We're out in San Francisco this week covering the amazing innovations that so many companies reveal at this annual conference.
The Dow Jones Industrial Average is higher Monday amid improved prospects for a trade deal between the U.S. and China.
The company expects revenue to jump 12% year over year.
Eli Lilly & Co. says Monday it will pay $8 billion in cash for cancer drug specialists Loxo Oncology in the second major pharmaceutical sector deal of the year.
Bigfoot Biomedical, Inc., a diabetes company using artificial intelligence to develop solutions for optimizing the dosing and delivery of insulin, today announced a non-exclusive cooperation agreement with Eli Lilly and Company (NYSE: LLY) to support...
Global stocks traded higher Monday, following on from Friday's spectacular rally on Wall Street, as investors cheered much stronger-than-expected U.S. jobs data paired with twin dovish messages from the Federal Reserve and the People's Bank of China that look to support beaten-down asset prices heading into the fourth quarter earnings season.
Pharma companies that have cash are looking at what has happened to this stock market and buying.
Whether this is the end of the slump is still up for debate, but the crash since October has been brutal and all bear markets end the same way.
A close below $105 for the drugmaker's shares would be bearish based on its charts.
Buying stocks now means you are in the uncomfortable position of fighting the Fed as it tries to slow the economy.
Stocks plunged Wednesday afternoon following the Federal Reserve's decision to raise rates by a quarter point.
Eli Lilly jumps Wednesday after it boosts its quarterly dividend and issues stronger-than-expected 2019 profits forecasts thanks to stronger demand for new medicines and its existing diabetes drug franchise.
We know we’re at the point where selling begets selling.
AC Immune SA (NASDAQ: ACIU) and Eli Lilly and Company (NYSE:LLY) today announced that the two companies have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of...
Lilly’s breakout has the stock poised to move through the $120 area.
Anticipating a weaker dollar thanks to the shift in the Fed, which stocks are most likely to benefit?
Pfizer pushes higher on price increases.
Pharma could be the best parking spot for your money if the market keeps trending downward.
Pfizer trades with a trailing PE of 15 and is expected to grow earnings 2% in 2019.
A split Congress is the best-case scenario for the drug industry, several analysts said.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AES, ALIM, APPS, EXAS, INVH, LBRDA, LBRDK, LLY, TLK Downgrades: CTT, DRH, HA, MTDR, ORIT, RNG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.